BioCentury
ARTICLE | Company News

Shire confirms AbbVie meeting

July 12, 2014 12:28 AM UTC

Shire plc (LSE:SHP; NASDAQ:SHPG) confirmed it held a meeting with representatives of AbbVie Inc. (NYSE:ABBV), but strongly advised shareholders to take no action in relation to AbbVie's proposal to acquire Shire in a deal valued at roughly L30.6 billion ($52.5 billion) in cash and stock. AbbVie did not provide comment in time for publication. ...